Article
Targeting GLP-1R and IL-17A suppresses obesity-induced leukemia in an oncogenic PTPN11 mutation-driven model.
The Journal of clinical investigation - 3 Aug 2026
Kapur Reuben, Li Linke, Kanumuri Rahul, Padam Kanaka Sai Ram, Ramdas Baskar, Pasala Chiranjeevi, Chiosis Gabriela, Palam Lakshmi Reddy, Kumar Ramesh, Koyama Satoshi, Natarajan Pradeep, Haneline Laura S, Yu Zhi, Pasupuleti Santhosh Kumar
Abstract excerpt
Obesity is increasingly implicated in hematopoietic malignancies, yet its role in mutation-driven myeloid leukemias remains unclear. Using UK Biobank data from over 440,000 individuals, we found obesity traits including elevated BMI and waist-to-hip ratio were associated with type 2 diabetes, increased plasma IL-17A levels, reduced glucagon-like peptide 1 receptor (GLP-1R) expression, and heightened risk of...
Topics
Join the communities discussing this publication.
